Diseases and Conditions

Thyroid disorders, diabetes, and high cholesterol dominate AI healthcare visits, reflecting a shift in how Americans manage long-term healthWhen patients visit an AI doctor, [...]

Important Note: Orforglipron is not yet FDA-approved. This medication is currently in clinical trials, with Eli Lilly planning to submit for regulatory review in late 2025, [...]

When flu season hits, many people wonder how to get quick treatment without waiting in crowded clinics. Tamiflu is a common antiviral medicine used to treat the flu, but can [...]

Important Note: Orforglipron is not yet FDA-approved. This investigational medication is in late-stage trials, with expected regulatory submission in late 2025 and potential [...]

Important Note: Orforglipron is not yet FDA-approved. Eli Lilly plans to submit for regulatory review in late 2025, with potential approval expected in 2026. Rybelsus (oral [...]

Important Note: Orforglipron is not yet FDA-approved. This investigational medication is in late-stage clinical trials, with regulatory submission planned for late 2025 and [...]

Important Note: Orforglipron is not yet FDA-approved. This investigational medication is in late-stage trials, with regulatory submission expected in late 2025 and potential [...]

Important Note: Orforglipron is not yet FDA-approved. Eli Lilly plans to submit for regulatory review in late 2025, with potential approval expected in 2026.For millions of [...]

Important Note: Orforglipron is a weight loss pill that is not yet FDA-approved. Eli Lilly plans to submit for regulatory approval in late 2025, with potential approval [...]

Important Note: Orforglipron is not yet FDA-approved. This medication is currently in clinical trials, with expected FDA submission in late 2025 and potential approval in [...]